Replies to post #518529 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

That’s remarkable trading by Biosect. Wished he had shared when he was selling, just to give everyone a heads up. But I guess that’s part of the game someone is better not sharing before putting in the sell order.

Biosect, congratulations on being up 60% a year on nwbo for 5 years (each year) that is remarkable trading. Clearly not just a buy and hold strategy as even had you purchased all your shares at 14 cents five years ago to average 60% per year nwbo would have to now be $1.50 a share. Nice trading!

[biosectinvestor]

I did not ever say to you I had or would give you such “examples”, every company’s circumstances are different. The 2 year is a reference from the end of trial/data lock to publication, which has not happened, and had nothing to do with quarterly conference calls. The quarterly conference calls have not happened for far longer than that. But there is no requirement of quarterly conference calls and since that had not happened for even longer and you’ve been fully aware of those facts and details. When it went to $2.51 did you sell? Have you doubled down over the time when there were no conference calls that you knew would not occur? Just curious why if that bothered one, one would not sell? Why is it up to me to explain to you since you've held all this time? I did not tell you to buy or hold. In fact, if I were you, I'd have sold years ago given your posts.

These are risky stocks. They are not for everyone. Every day there is a risk of TOTAL and COMPLETE loss. I'm sure you know that though, or should know it given the risk factors in their disclosures.

[biosectinvestor]

That’s the 5 year if you just compare against the current price.

But yes, not trading, big buys at cheap prices, small buys when it was higher, and yes, I sold off expensive shares for various reasons sometimes against gains, and then bought more and sometimes for small profits against other losses. Generally I worked hard to maximize my low cost shares and keep my transaction costs low. You should try it.

[biosectinvestor]

Apparently my reasonable answer no longer exists and there is no point as I have explained this to you numerous times, including that your 2 year issue is about a quiet period related to final results (which is not the same thing as the conference call issue) but you already know quite a bit about them, so not really actually an absence of information. In fact, some might say we are privileged to be so attentive to understand what is going on and still be able to buy cheap, if you’re still buying.

I’ve explained why it is reasonable and why I never promised to give you comparables because every trial and circumstance is different, this is OTC, and they are up-to-date on their reporting. They are OTC for particular reasons and the trial I explained also, but re-writing it all out again is a waste of time. If you missed it, your tough luck.